The Department of Neurology is actively involved in clinical trials to determine the effectiveness of new medications to treat neuromuscular diseases and disorders. If you are interested in receiving additional information or participating in a trial, please e-mail or call the persons listed below. Please note that enrollment is currently closed for some of the trials.
Enrollment is closed.
Amgen Corporation D iabetic Neuropathy Trials Nerve Growth Factor for moderately severe diabetic peripheral neuropathy Study completed. Genentech E pilepsy Trials Sabril for Epilepsy Study ongoing. Enrollment open to patients with newly diagnosed Parkinson's disease who are not on Sinemet. Enrollment open to patients with advanced Parkinson's disease with motor flucuations. Enrollment open to patients who have a sibling with the same disease.